SEC Form 4 · accession 0000950138-19-000037
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George A. Kegler
Officer — EVP & CFO, Interim
Period of report
Jan 9, 2019
Accepted (ET)
Jan 11, 2019 · 4:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jan 9, 2019 | F | 81 | $19.27 | D | 14,985 | D |
Table II — derivative securities
No Table II lines on this filing.